期刊文献+

新疆维吾尔族和汉族多囊卵巢综合征临床特征分析 被引量:8

Clinical Features of Polycystic Ovary Syndrome among Uygur and Han People in Xinjiang
下载PDF
导出
摘要 目的探讨维吾尔族(维族)和汉族多囊卵巢综合征(PCOS)患者的临床特征及相关物质代谢之间的差异。方法 回顾性分析我院2009年8月—2010年5月收治的210例PCOS患者的临床特征以及各项临床检查指标,其中汉族132例、维族78例。结果 (1)维汉两族患者的年龄、体质指数、腰臀比间差异无统计学意义(P>0.05),两组患者均存在月经稀发情况(汉族52.38%、维族46.15%),但差异无统计学意义(P>0.05)。两组F-G分数(汉族42/132、维族59/78)间差异有统计学意义(P<0.05)。(2)维族和汉族的黄体生成素/卵泡雌激素〔汉族(2.06±1.19)、维族(2.79±1.97)〕间差异有统计学意义(P<0.05)。(3)维族和汉族总胆固醇水平间差异有统计学意义(P<0.05)。结论按照ESHRE/ASRM诊断标准,维、汉两族育龄妇女PCOS患者的稀发排卵、卵巢多囊B超表现以及胰岛素代谢方面无明显差异,而女性内分泌及血脂代谢方面有差异,应重视PCOS疾病引起患者体内物质代谢紊乱的现象以及积极预防后期并发症。 Objective To discuss the differences of clinical features and metabolism between Uygur and Han patients with polycystic ovary syndrome. Methods According to the Revised 2003 European Society for Human Reproduction and Embryology/American Society for Reproductive Medicine criteria PCOS can be diagnosed with 2 manifestations out of oligo-or anovulation,clinical and/or biochemical signs of hyperandrogenism exclusion of other etiologies and polycystic ovaries.Two hundred and ten PCOS patients(Han patient 132,Uygur 78) admitted into the clinic of the First Affiliated Hospital of Xinjiang Medical University from August 2009 to May 2010 were included in this retrospective study. Results(1) There were no differences between two groups in age,body mass index and waist-hip ratio(P〉0.05).Oligomenorrhea showed no difference between the two groups(Han patient 52.38%,Uygur 46.15%).The relevant sample size was less than normal.F-G scores of the two groups were significantly different(Han patient 42/132,Uygur 59/78) and were specifically related to race.(2) LH/FSH ratios of Uygur(Uygur 2.79±1.97,Han patient 2.06±1.19) were significantly higher than that of Han patients(P〈0.05).(3) The difference of total cholesterol between the two groups was statistically significant(P〈0.05). Conclusion According to ESHRE/ASRM criteria,no significant differences are found in oligomenorrhea,Type-B ultrasonic manifestation of polycystic ovary and insulin metabolism between Uygur and Han childbearing age women with PCOS,but significant differences are found in endocrine and blood lipid metabolism.Great importance should be attached to the metabolic disorders caused by PCOS and late stage complications should also be prevented positively.
出处 《中国全科医学》 CAS CSCD 北大核心 2011年第15期1656-1658,共3页 Chinese General Practice
关键词 多囊卵巢综合征 症状和体征 汉族 维吾尔族 Polycystic ovary syndrome Symptoms and signs Han nationality Uygur nationality
  • 相关文献

参考文献14

  • 1陈子江,李媛,周灿权,黄荷凤,刘嘉茵,乔杰,黄国宁,梁晓燕,郁琦.多囊卵巢综合征与辅助生殖的热点问题讨论[J].现代妇产科进展,2004,13(4):241-250. 被引量:58
  • 2Rotterdan ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome[J].Fertil Steril,2004,81:19-25.
  • 3Azziz R.The evaluation and management of hirsutism[J].Obstet Gynecol,2003,101:995-1007.
  • 4李秀均.胰岛素抵抗综合征[M].北京:人民卫生出版社,2001.156-159.
  • 5Azziz R,Woods KS,Reyna R,et al.The prevalence and features of the polycystic ovary syndrome in an unselected population[J].J Clin Endocr Metab,2004,89:2745-2749.
  • 6Chen XL,Yang DZ,Li L,et al.Prevalence of polycystic ovary syndrome in unselected women from southern China[J].Eur J obstet Gynecol,2008,139:59-64.
  • 7Li L,Yang DZ,Chen XL,et al.Clinical and metabolic features of polycystic ovary syndrome[J].Int J Gynecol Obstet,2007,97(2):129-134.
  • 8Balen A,Homburg R,Franks S.Defining polycystic ovary syndrome[J].BMJ,2009,338(26):2968-2971.
  • 9郑俊,滕香宇,刘伟.噻唑烷二酮类药物改善多囊卵巢综合征患者胰岛素抵抗的作用[J].中国全科医学,2009,12(20):1920-1922. 被引量:22
  • 10张学艳,杨秋平,逯静茹.多囊卵巢综合征代谢特点及干预治疗的临床研究[J].河北医药,2009,31(13):1606-1607. 被引量:4

二级参考文献50

共引文献129

同被引文献58

  • 1林金芳,李昕,朱铭伟.多囊卵巢综合征的分型探讨[J].中华妇产科杂志,2006,41(10):684-688. 被引量:74
  • 2郑成竹,胡兵.腹腔镜手术治疗肥胖病的新概念[J].中华消化外科杂志,2007,6(3):164-165. 被引量:23
  • 3李克敏.妇科内分泌掌中宝[M].2版.北京:北京医科大学出版社,2009:46-47.
  • 4Martínez-Bermejo E,Luque-Ramírez M,Escobar-Morreale HF.Obesity and the polycystic ovary syndrome[J].Minerva Endocrinol,2007,32(3):129-140.
  • 5Teede HJ,Hutchison S,Zoungas S,et al.Insulin resistance,themetabolic syndrome,diabetes,and cardiovascular disease risk inwomen with PCOS[J].Endocrine,2006,30(1):45-53.
  • 6Pasquali R,Gambineri A,Pagotto U.The impact of obesity onreproduction in women with polycystic ovary syndrome[J].BJOG,2006,113(10):1148-1159.
  • 7Magnotti M,Futterweit W.Obesity and the polycystic ovary syndrome[J].Med Clin North Am,2007,91(6):1151-1168.
  • 8Celik O,Celik N,Hascalik S et al.An appraisal of serum prep-tin levels in PCOS(J).Fertil Steril,2011,95(1):314.
  • 9Magnotti M,Futterweit W.Obesity and the polycystic ovary syndrome(J).Med Clin North Am,2007,91(6):1151.
  • 10Yang G,Li L,Chen W et al.Circulating peptin levels in nor-mal,impaired glucose tolerance,and type 2 diabetic subjects(J).Ann Med,2009,41(1):52.

引证文献8

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部